Consensus ImpediMed Limited

Equities

IPD

AU000000IPD8

Delayed Australian S.E. Other stock markets 00:13:55 2024-05-02 EDT			5-day change	1st Jan Change
0.079 ^AUD	-1.25%		-12.22%	-45.52%

04-30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
04-30	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Evolution of the average Target Price on ImpediMed Limited

Price target over the last 5 years

History of analyst recommendation changes

1da7eb17b8d328f99581f2e838838.3JDpB0IUmttk_qqqyhr8IXCto1r3e1HzTpY-M-fSeJE.pdugbDNtquNU0-vnuF7IRB_8kyuhEyCpK_lMeYu8NeKDyYJeDXzClTzMzQ~f5bf1a22dcfadbcc96a5ec5c10c9b975

Analyst Recommendations on ImpediMed Limited

Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	04-16	MT
ImpediMed Limited Announces Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer Related Lymphedema	22-10-26	CI